Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine Signaling Pathways and Extracellular Matrix (ECM) Environment refers to the integrated system of local cellular communication and the non-cellular structural framework that regulates tissue physiology. Paracrine signaling involves the secretion of molecules such as growth factors, cytokines, and chemokines that act on nearby cells to coordinate development, immunity, and repair (Alberts et al., 2002). The ECM provides the physical scaffolding for cells while simultaneously acting as a reservoir for these signaling molecules and transmitting mechanical cues through receptors like integrins (Hynes, 2009). In pathological conditions like cancer and chronic fibrosis, these pathways and the ECM architecture become severely dysregulated, forming a 'reactive stroma' that promotes uncontrolled cell growth, metastasis, and resistance to therapy (Lu et al., 2012). While this entry describes a broad biological context rather than a single molecular target, specific individual components within this environment—such as Vascular Endothelial Growth Factor (VEGF) or Transforming Growth Factor-beta (TGF-β)—are major focuses of drug development (Quail & Joyce, 2013). Targeted therapies often aim to disrupt these local signaling loops or degrade excessive ECM components to restore normal tissue function or enhance the delivery of other medications.
Modulation of growth factor availability, inhibition of extracellular matrix remodeling enzymes (e.g., MMPs), blockade of integrin-mediated cell adhesion, or neutralization of paracrine ligands.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine Signaling Pathways and Extracellular Matrix Environment.